Wednesday, September 6 and Friday, September 8, 2023, 12:30 PM – 2:45 PM CDT
2V. Introduction to the Science and Biosafety of Cell and Gene Therapy Clinical Trials
The use of recombinant and synthetic nucleic acid molecules in clinical trials is growing at an explosive pace. This course is intended to introduce biosafety professionals to the science and biosafety of gene-based investigational products in clinical trials including gene-based vaccines, gene modified cellular products, gene therapy and gene editing. This course will provide an overview of molecular biology, virology and viral vectors. Participants will discuss risk assessments and best practices for dealing with risks associated with diverse types of biological hazards.
Objectives:
- Restate the basic molecular biology and microbiological principles behind gene-based vaccines, gene modified cellular therapies and gene therapies
- Summarize how to conduct a risk assessment for gene-based vaccines, gene modified cellular therapies and gene therapies
- Overview of viral vectorology (properties, uses, and risks associated with commonly utilized viral vectors)
Suggested Background: None
Target Audience: All Safety Professionals, Laboratory Workers, Research Administrators, Clinical Professionals
Audience Level: Basic
Course Length: 4 hours (two 2-hour live sessions with a 15-minute break each session)
This webinar will be two 2-hour webinar sessions on Wednesday, September 6 and Friday, September 8, 2023, 12:30 PM – 2:45 PM CDT. For the webinar, you should plan on logging in at 12:15 pm (CDT) on September 6 and September 8. You are required to attend the webinar sessions, complete the pre-course and post course assessments, and complete the evaluation in order to receive the completion certificate through the ABSA International Training Site. The link in the invitation will be unique to the user and cannot be shared.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 4.0 P.A.C.E.® contact hours.
COURSE FACULTY
COURSE FEES
ABSA Members: $390 USD (post 9/4 – $440)
Nonmembers: $490 USD (post 9/4 – $540)
To obtain the ABSA member rate, the participant will need to be an ABSA member in the year in which the training is offered. Course fees include: course handouts, access to the ABSA International training site, and 4-hours of interactive instruction from a well-respected subject matter expert.
Confirmed, paid participants will be sent detailed information regarding the course approximately one week prior to the course. Substitutions allowed with notice by 8/9/2023. There is a 15% processing fee for cancellations prior to 8/9/2023. Cancellations between 8/9/2023 and 8/16/2023 will be refunded at 50% of the course fee. No refunds after 8/16/2023.
The links to the various invitations for the course will be unique to the user and cannot be shared. The links are for single, individual use only. If more than one occurrence of an individual’s name is on the attendee list for the webinar through Zoom platform all instances of that person’s name will be removed from the webinar with no refund. The webinar and its associated links are for single, individual use only.





You must be logged in to post a comment.